Medipharm labs files proxy materials, issues chair's letter to shareholders

Toronto , may 13, 2025 /prnewswire/ - medipharm labs corp. (tsx: labs) ("medipharm" or the "company"), a pharmaceutical company specialized in precision-based cannabinoids, has filed its management information circular ("mic" or the "circular") and proxy materials (the "meeting materials") for its upcoming annual and special meeting of shareholders, scheduled for june 16, 2025. the meeting materials will be sent to shareholders in the coming days, and are available on the sedar+ website at www.sedarplus.ca.
CHEK Ratings Summary
CHEK Quant Ranking